10-May-2024
AREX Capital Expresses Disappointment in Enhabit's Strategic Review Conclusion
Globe Newswire (Thu, 9-May 9:15 AM ET)
Addus HomeCare to Participate in BofA Securities Health Care Conference 2024
Business Wire (Tue, 7-May 11:00 AM ET)
TipRanks (Tue, 7-May 8:21 AM ET)
Addus Homecare (ADUS) Receives a Rating Update from a Top Analyst
TipRanks (Tue, 7-May 8:17 AM ET)
Addus Homecare: A Robust Financial Performance and Bullish Stock Outlook
TipRanks (Tue, 7-May 5:19 AM ET)
Addus HomeCare Announces First Quarter 2024 Financial Results
Business Wire (Mon, 6-May 4:05 PM ET)
Addus HomeCare Comments on Final Department of Health and Human Services Rule
Business Wire (Tue, 23-Apr 8:00 AM ET)
Addus HomeCare Announces First Quarter 2024 Earnings Release and Conference Call
Business Wire (Mon, 22-Apr 11:00 AM ET)
Business Wire (Tue, 5-Mar 11:00 AM ET)
Business Wire (Tue, 27-Feb 11:00 AM ET)
Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the segments such as Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are primarily medical in nature to those individuals who may require assistance during an illness or after surgery.
Addus Homecare trades on the NASDAQ stock market under the symbol ADUS.
As of May 10, 2024, ADUS stock price climbed to $109.26 with 108,894 million shares trading.
ADUS has a beta of 0.55, meaning it tends to be less sensitive to market movements. ADUS has a correlation of 0.06 to the broad based SPY ETF.
ADUS has a market cap of $1.79 billion. This is considered a Small Cap stock.
Last quarter Addus Homecare reported $281 million in Revenue and $1.21 earnings per share. This beat revenue expectation by $1 million and exceeded earnings estimates by $.12.
In the last 3 years, ADUS stock traded as high as $114.99 and as low as $68.57.
The top ETF exchange traded funds that ADUS belongs to (by Net Assets): IJR, VTI, IWM, VXF, SPSM.
ADUS has outperformed the market in the last year with a price return of +33.3% while the SPY ETF gained +27.8%. ADUS has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +15.9% and +15.6%, respectively, while the SPY returned +4.2% and +2.5%, respectively.
ADUS support price is $103.35 and resistance is $108.85 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ADUS stock will trade within this expected range on the day.